Patents by Inventor Karin Granath

Karin Granath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9894746
    Abstract: Target windows for isotope production systems are provided. One target window includes a plurality of foil members in a stacked arrangement. The foil members have sides, and wherein the side of a least one of the foil members engages the side of at least one of the other foil members. Additionally, at least two of the foil members are formed from different materials.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: February 13, 2018
    Assignee: General Electric Company
    Inventors: Jonas Ove Norling, Karin Granath
  • Publication number: 20130259180
    Abstract: Target windows for isotope production systems are provided. One target window includes a plurality of foil members in a stacked arrangement. The foil members have sides, and wherein the side of a least one of the foil members engages the side of at least one of the other foil members. Additionally, at least two of the foil members are formed from different materials.
    Type: Application
    Filed: March 30, 2012
    Publication date: October 3, 2013
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Jonas Ove Norling, Karin Granath
  • Patent number: 6492382
    Abstract: The present invention relates to dried preparations containing a class III antiarrhythmic compound in the form of a crystalline or amorphous salt or any combination thereof, where the counterion is selected from pharmaceutically acceptable water-soluble organic or inorganic acids. The present invention also relates to frozen preparations containing a class III antiarrhythmic compound in the form of a salt solution, where the counterion is selected from pharmaceutically acceptable water-soluble organic or inorganic acids. Preferred preparations contain a salt of the compound 3,7-diazabicyclo[3.3.1]-nonane-3-carboxylic acid, 7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-1,1-dimethylethyl ester (Compound A). Further aspects of the present invention include salts of Compound A per se, processes for preparing the preparations, as well as use of the preparations for prophylaxis and/or treatment of cardiac arrhytmia.
    Type: Grant
    Filed: November 3, 1999
    Date of Patent: December 10, 2002
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Anna-Karin Granath